This is the sixth in our 2024 Year in Preview series examining important trends in white collar law and investigations in the coming year. We will be posting further installments in the series throughout the next several...more
3/8/2024
/ China ,
Corporate Governance ,
Critical Infrastructure Sectors ,
Drug Pricing ,
Educational Institutions ,
Energy Projects ,
Environmental Social & Governance (ESG) ,
Healthcare ,
Legislative Agendas ,
Medicare Advantage ,
New Legislation ,
New Regulations ,
Pharmaceutical Industry ,
Private Equity ,
Regulatory Agenda ,
Social Media ,
Supply Chain ,
Supply Shortages ,
White Collar Crimes
Congressional Activity -
The challenges around addressing health concerns related to per- and polyfluoroalkyl substances (PFAS) are immense. The Environmental Protection Agency (EPA) states that PFAS are widely used, long...more
This is the tenth and final post in this year’s series examining important trends in white collar law and investigations. Be on the lookout for a roundup of our 2022 White Collar Year in Preview Series shortly....more
3/17/2022
/ Big Tech ,
Climate Change ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Cost-of-Living Adjustment (COLA) ,
Cryptocurrency ,
Drug Pricing ,
Financial Services Industry ,
Healthcare ,
Legislative Agendas ,
Organ Transplant Centers ,
Social Media ,
Special Purpose Acquisition Companies (SPACs) ,
Technology Sector ,
White Collar Crimes